Latest news with #Paolone
Yahoo
02-04-2025
- Business
- Yahoo
Kilroy Realty Appears Cheap From Real Estate Valuation Perspective: Analyst
J.P. Morgan analyst Anthony Paolone maintained the Overweight rating on Kilroy Realty Corporation (NYSE:KRC) on Tuesday, lowering the price forecast to $42 from $49. Paolone expresses a positive view on the company's portfolio, highlighting its high-quality assets and strong balance sheet compared to other office REITs. According to the analyst, leasing activity in key West Coast markets will improve in the near future, especially as tech companies push to bring employees back to the office. Additionally, the analyst projects operational expense growth to stabilize. Looking ahead, Paolone sees improvement in the capital markets for office assets in 2025, which could help reveal that the company's stock is currently undervalued. Also Read: The analyst notes that, based on a 9%+ implied cap rate for the company's portfolio and a current occupancy rate of around 80%, the stock appears cheap from a real estate valuation perspective. Paolone points out that during peak cycles, Kilroy Realty's assets were valued at cap rates in the low 4% range, further supporting their view that the stock is discounted. The analyst has revised their financial outlook for 2025 and 2026, lowering their FFO/share estimates. For 2025, the revised estimate is $4.01, which is slightly above Bloomberg's consensus of $3.99 and ahead of the midpoint of the company's guidance at $3.95, the analyst writes. However, the estimate for 2026 has been reduced more significantly to $3.52, reflecting a 12.3% year-over-year decline, and is notably below Bloomberg's consensus of $3.85. Per Paolone, the key factor driving these downward revisions is a reduction in capitalized interest, which comes from assuming that another $1 billion in land and projects, not part of KOP II, will be excluded from active development. This includes an estimated $600+ million in capital from the Flower Mart project, over $200 million from the SIX0 development, and an additional $100-$200 million from various smaller projects, contributing to the lowered projections, Paolone adds. Price Action: KRC shares are trading higher by 1.10% to $33.22 at last check Wednesday. Read now:Photo via Shutterstock. Date Firm Action From To Mar 2022 Evercore ISI Group Downgrades Outperform In-Line Feb 2022 B of A Securities Upgrades Neutral Buy Jan 2022 Mizuho Upgrades Neutral Buy View More Analyst Ratings for KRC View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? KILROY REALTY (KRC): Free Stock Analysis Report This article Kilroy Realty Appears Cheap From Real Estate Valuation Perspective: Analyst originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
CBC
15-03-2025
- Health
- CBC
Elderly patients can deteriorate hourly in the ER. This team works against the clock to get them out
It's 7 a.m. in the emergency department of St. Mary's Hospital in Montreal, and geriatric nurse Leeza Paolone is starting her day in front of a screen filled with patient names, taking note of each one highlighted in blue. "We're fighting against the clock to get these patients seen, and hopefully out of there," Paolone told Dr. Brian Goldman, host of CBC Radio's White Coat, Black Art. The blue names belong to patients 75 and over who've been identified by triage nurses as at risk of functional decline in the hospital. The longer these patients spend in the ER, the worse their outcomes are likely to be, due to a phenomenon known as hospital-associated deconditioning. It refers to physical and often cognitive decline that happens as a result of being hospitalized. The geriatric multidisciplinary ER team at St. Mary's targets these patients from the moment they arrive. Given the number of Canadians 85 and over will triple in the next 20 years, medical professionals and researchers are sounding the alarm about keeping older adults out of the hospital, spreading the word that — perhaps counterintuitively — the hospital isn't always the safest place for them. Research has shown that deconditioning is a catastrophe for elderly patients in hospital ERs. A study published in the Canadian Geriatrics Journal in 2017 found that one in five patients over 65 developed delirium — a serious change in mental state involving confusion and a lack of awareness — after spending 12 hours in the ER. It also found that delirium often extends hospital stays by a week or more, setting in motion a domino of decline. At worst, an elderly person enters the hospital as someone who lives independently and never goes home. ERs not designed for the elderly To avoid this, the first step is preventing an elderly patient from waiting a second longer than needed. "In the ER specifically, the environment can be much harder on the geriatric patient," says Paolone. With the frenetic surroundings of an ER — lights and noise that disrupt sleep, no windows, meals and medication given sporadically or skipped — a patient can grow delirious in just a couple of hours. Then they have to be admitted. And that's bad news, says geriatrician Dr. Julia Chabot, the team's co-founder. "We know that for every day an elderly patient spends in a bed or on a stretcher, it will take an average of three days for them to recover." Santé Québec warns against unnecessary ER visits as occupancy rates soar Plus, once a geriatric patient is admitted, their average stay at St. Mary's is 28 days, which costs the hospital tens of thousands of dollars, says Chabot. So the mission of this team — just over halfway through a two-year pilot — is to proactively screen, assess and treat elderly ER patients in the hope they can be discharged with proper support in place. On any given day, nurse Leeza Paolone is joined by a physiotherapist, occupational therapist, social worker and one of four geriatricians. Preventing ER 'bouncebacks' One "blue" patient on the triage board the day White Coat, Black Art observed is 84-year-old Maria Pastore, who's come in with painful bursitis in her hip made worse by a recent fall. She also has a blood clot in her leg. This is the third Montreal ER she's been to in the past few months. At the first, she was given a cortisone shot in her hip following a 10-hour wait. At the second, a prescription for a walker. But with no follow-ups to make sure, she never got it. For the team at St. Mary's, one major goal is to prevent "bouncebacks" like this. "She needs the follow-up, otherwise she's going to end up at different ERs throughout the city," says physiotherapist Natalie Ilienko. Ilienko and occupational therapist Stephanie Yung do a detailed intake encompassing everything from how independent Pastore is — she does her own cooking and cleaning — to her medical history, physical strength, medications and mobility. Leeza Paolone chats with Pastore in Italian, which, she tells Dr. Brian Goldman, she learned from the grandparents who helped raise her. "They're the strongest people I know," said Paolone. Paolone starts stitching together a care plan. Pastore is a widow; her son lives in New York, and she has no family doctor. But when Paolone makes a call to the seniors' residence where she lives, it turns out there is a family doctor who works on site. An hour later, everything is set up. "So we have a rheumatology follow up. We have a hematology follow up… And I'm going to fax everything to the doctor at the residence." She also updates hospital records with Pastore's current phone number — a small but crucial detail given the appointments and follow-ups now on the books. Longer waits, higher mortality Dr. Robert Drummond, an emergency medicine specialist who has worked at St. Mary's for 30 years, says when the elderly have to wait, "it's not a mere inconvenience for them. It represents a greater risk for morbidity and mortality." A 2023 study from France found that patients 75 years and up who waited overnight in the ER had a "significantly higher in-hospital mortality rate." Drummond says the new ER team has "made a huge difference. They're very proactive." For example, the team gauges whether sufficient supports are in place for geriatric patients to go home, and gets them the right care when that's not the case. Like when they learn patient Thi Truong Nguyen, 77, lives at a Buddhist temple where she won't get the round-the-clock help she needs to recover from a shoulder fracture. "I feel lucid," says Nguyen, "but I cannot move much." Yung and Ilienko fit Nguyen with a sling to help the shoulder heal, and request an orthopedic consult to determine whether surgery is needed. But Nguyen uses a walker, and that won't work with only one good arm. So the team requests a transfer to a rehab facility and gets her a bed upstairs while she waits. Connecting the dots Elderly patients who need Nguyen's level of care are the norm, not the exception, says Dr. Brittany Ellis, an ER doctor in Saskatoon and chair of the Geriatric Emergency Medicine Committee for the Canadian Association of Emergency Physicians (CAEP). CAEP data shows seniors make up 20 to 40 per cent of all ER patients. Ellis says access to comprehensive geriatric ER care is "extremely variable" across Canada. Though she knows of only a "handful" of teams comparable to St. Mary's, she says there are ER-delirium-prevention programs in provinces like Saskatchewan, B.C., and Newfoundland and Labrador. Ontario, meanwhile, has implemented a program to train nurses in geriatric emergency care. With some creativity, Ellis she says it's possible to apply this approach anywhere. "For example, a small hospital probably doesn't have in-house physiotherapy, occupational therapy, geriatricians, or a pharmacy," she says, but could partner with these other experts in the community for more comprehensive care. Discharging quickly and safely While the St. Mary's pilot is still underway, Dr. Chabot said preliminary data are promising enough she's confident the team will become permanent. Geriatric patients now spend an average of 10.5 hours less in the ER than before, and 28 per cent fewer are admitted. Like Maria Pastore, who the team is determined to get safely on her way by the end of day. Ilienko arrives with a brand-new walker, free of charge because it's covered by the province for her condition. The team helps Pastore get up, adjusts the walker to fit, then stands back as she makes her way down the corridor with her new wheels. "Wonderful. She looks steadier," says Chabot. "As a whole team, I think this was a great intervention."
Yahoo
08-03-2025
- Business
- Yahoo
COPT Defense Properties Faces Risks: Analyst Sees Uncertainty In Leasing Process Amid Budget Cut Risks
JP Morgan analyst Anthony Paolone maintained the Neutral rating on COPT Defense Properties (NYSE:CDP), lowering the price forecast to $29 from $31. The analyst suggests that while COPT Defense Properties' management execution and business trends offer good visibility for expected growth, some emerging risks have been identified. The most significant risk is related to DOGE, as any potential reduction in the DOD's budget or changes in contract awards by the Federal government could slow COPT Defense Properties' leasing process. However, Paolone finds it unlikely that the core missions supported by COPT Defense Properties' portfolio, such as cybersecurity and critical command functions, would suddenly become less relevant, though the way funds are allocated could change. Also Read: The analyst writes, there is some anticipation surrounding COPT Defense Properties' Huntsville market potentially being awarded the Space Command HQ, which has not yet occurred. If another area becomes a contender for the command, it could reduce demand for build-to-suit projects. Additionally, the analyst notes that a key part of the company's future development growth involves data center shells for AWS in Des Moines, Iowa. However, if the company cannot secure power or its tenant decides to proceed at a slower pace, it could impact the pipeline. Finally, the analyst mentions that while COPT Defense Properties plans to sell its regional office assets, these sales could be dilutive to earnings growth and are not included in the company's multi-year FFO CAGR forecast. Price Action: CDP shares closed lower by 1.26% to $26.67 on Thursday. Read Next:Photo by Ground Picture on Shutterstock. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article COPT Defense Properties Faces Risks: Analyst Sees Uncertainty In Leasing Process Amid Budget Cut Risks originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
07-03-2025
- Business
- Yahoo
COPT Defense Properties Faces Risks: Analyst Sees Uncertainty In Leasing Process Amid Budget Cut Risks
JP Morgan analyst Anthony Paolone maintained the Neutral rating on COPT Defense Properties (NYSE:CDP), lowering the price forecast to $29 from $31. The analyst suggests that while COPT Defense Properties' management execution and business trends offer good visibility for expected growth, some emerging risks have been identified. The most significant risk is related to DOGE, as any potential reduction in the DOD's budget or changes in contract awards by the Federal government could slow COPT Defense Properties' leasing process. However, Paolone finds it unlikely that the core missions supported by COPT Defense Properties' portfolio, such as cybersecurity and critical command functions, would suddenly become less relevant, though the way funds are allocated could change. Also Read: The analyst writes, there is some anticipation surrounding COPT Defense Properties' Huntsville market potentially being awarded the Space Command HQ, which has not yet occurred. If another area becomes a contender for the command, it could reduce demand for build-to-suit projects. Additionally, the analyst notes that a key part of the company's future development growth involves data center shells for AWS in Des Moines, Iowa. However, if the company cannot secure power or its tenant decides to proceed at a slower pace, it could impact the pipeline. Finally, the analyst mentions that while COPT Defense Properties plans to sell its regional office assets, these sales could be dilutive to earnings growth and are not included in the company's multi-year FFO CAGR forecast. Price Action: CDP shares closed lower by 1.26% to $26.67 on Thursday. Read Next:Photo by Ground Picture on Shutterstock. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article COPT Defense Properties Faces Risks: Analyst Sees Uncertainty In Leasing Process Amid Budget Cut Risks originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
14-02-2025
- Business
- Yahoo
Entero Therapeutics Appoints Richard Paolone as CEO
BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) ('Entero' or the 'Company'), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that the board of directors has appointed Mr. Richard Paolone as the interim CEO of the Company. Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range of strategic business initiatives and has represented numerous companies in both private and public offerings of debt and equity securities, comprehensive understanding of capital markets and regulatory environments. His advisory work has been pivotal to several successful M&A and go-public transactions. In addition to his transactional work, Mr. Paolone has built a reputation as a trusted advisor to management teams and boards, ensuring legal and regulatory compliance in Canada while facilitating business growth. His broad experience also includes serving as a director or officer for several private and publicly traded companies, where he continues to provide strategic insights and governance expertise to help guide their success in competitive markets. For more information about Entero Therapeutics, visit and connect on X and LinkedIn. About Entero Therapeutics Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and include: latiglutenase, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more information visit For more information:Entero Therapeutics, Inc.777 Yamato Road, Suite 502Boca Raton, FL 33431Phone: (561) 589-7020info@ Investor contact information:Entero Investor Relationsinvestors@ in to access your portfolio
